APP and Alzheimer disease: Approximately 220 pathogenic mutations in the PSEN1 gene have been reported in AD patients worldwide, whereas 27 and 16 pathogenic mutations have been described in the APP and PSEN2 genes, respectively (Cruts et al., 2012).